Rezolute, Inc. (RZLT)
1.625
-0.18
(-9.72%)
USD |
NASDAQ |
Dec 15, 13:34
Rezolute Research and Development Expense (Quarterly): 13.15M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Geron Corp. | 21.07M |
| XOMA Royalty Corp. | 0.069M |
| Sarepta Therapeutics, Inc. | 218.89M |
| Astria Therapeutics, Inc. | 24.15M |